Torrent Pharma tanks 4% post Q1FY25 results; analysts update target prices

Quick Summary:

Shares of Torrent Pharma slumped up to 4.26 per cent at Rs 646.70 per share on the BSE in Tuesday's intraday deals.

The brokerage expects Torrent’s revenue and PAT growth of 10 per cent and 24 per cent, respectively over FY24-27.

The company's revenue from operations also saw a growth of 10 per cent Y-o-Y, rising to Rs 2,859 crore compared to Rs 2,591 crore in Q1FY24.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: IndiaBrazilGermany

Topics: Market news Torrent pharma q1fy25 results Torrent pharma Torrent pharma q1 results Torrent pharma share price Pharma news Sensex Nifty Pharma sector Torrent pharma share price today

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-07-24 @ 11:53:23 (7 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 510 words

Reading Time: 3 minutes read

Sentences: 20 lines

Sentence Length: 26 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 21759936

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 279 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions